www.qiagen.com Open in urlscan Pro
2620:1ec:29:1::64  Public Scan

Form analysis
0 forms found in the DOM

Text Content

We've reimagined clinical dPCR: Discover QIAcuityDx
 * Products
 * Applications & Insights
 * Knowledge & Support
 * About QIAGEN
   

   
 * Quick Order
   
 * 0 Cart
 * My QIAGEN
   
   



 * Experiment Configurator
   
   
 * Discovery & Translational Research
   
   
 * Diagnostics & Clinical Research
   
   
 * Human ID & Forensics
   
   
 * Next-Generation Sequencing
   
   
 * Instruments & Automation
   
   
 * Informatics & Data
   
   
 * Services
   
   
 * Strategic partnerships
   
   
 * Top Sellers
   
   
 * New Solutions
   
   
 * Shop
   
   
   




Enzymes for molecular biology

Explore high-quality enzymes; now available as individual products.



Products and tools for your targets

Explore targets and pathways in their scientific context, find and customize
products to study them, analyze data and plan follow-up studies – all in
GeneGlobe.



QuantiFERON-TB Gold Plus

Detect TB infection with confidence.




Looking for a quick way to design experiments?
Try the Workflow Configurator. A convenient tool to build experimental workflows
and find products to match your needs.
Welcome to My QIAGEN
Dashboard
Account
Orders
Log Out

icon_0147_cc_gen_global-s DE Afghanistan Albania Algeria American Samoa Andorra
Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia
Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belgium Belize Benin
Bermuda Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana
Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands
Brunei Darussalam (Brunei) Bulgaria Burkina Faso Burundi Cabo Verde Cambodia
Cameroon Canada Cayman Islands Central African Republic Chad Chile China
Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands
Costa Rica Croatia Cyprus Czech Republic Democratic Republic of the Congo
Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador
Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe
Islands Federated States of Micronesia Fiji Finland France French Guiana French
Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana
Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea
Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong
Hungary Iceland India Indonesia Iraq Ireland Israel Italy Ivory Coast Jamaica
Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic
Republic Latvia Lebanon Lesotho Liberia Libia Liechtenstein Lithuania Luxembourg
Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique
Mauritania Mauritius Mayotte Mexico Moldova Monaco Mongolia Montserrat Morocco
Mozambique Myanmar (Burma) Namibia Nauru Nepal Netherlands Netherlands Antilles
New Caledonia New Zealand Nicaragua Niger Nigeria Niue North Macedonia Northern
Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru
Philippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Reunion Romania
Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint
Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San
Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone
Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia
and the South Sandwich Islands South Korea Spain Sri Lanka Sudan Suriname
Svalbard and Jan Mayen Swaziland Sweden Switzerland Taiwan Tajikistan Tanzania
Thailand Togo Tokelau Timor-Leste Tonga Trinidad and Tobago Tunisia Türkiye
Turkmenistan Turks and Caicos Islands Tuvalu U.S. Virgin Islands Uganda Ukraine
United Arab Emirates United Kingdom United States Minor Outlying Islands United
States of America Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam
Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe
icon_0058_speech_bubble-s DE Chinese (Simplified, PRC) Japanese (Japan) Korean
(Korea) French German Spanish English


WELCOME TO QIAGEN!

You can accept or revoke the cookies used on this website at any time with the
selection below or by adjusting your cookie settings. For complete details about
our cookies, see our Cookie Policy.
Customize Only necessary Accept all
 1. Home
 2. Trademarks & Disclaimers


TRADEMARKS & DISCLAIMERS

 

REGISTERED OR REGISTRATION-PENDING TRADEMARKS OF THE QIAGEN GROUP:

QIAGEN®, Sample to Insight®, QIA®, QIAamp®, QIAamplifier®, QIAcard®, QIAcube®,
QIAcuity®, QIAcuityDx®, QIAEX®, QIAexpress®, QIAgility®, QIAlab®, QIAlink®,
QIAprep®, QIAprep&amp®, QIAGEN Quality®, QIAquant®, QIAquick®, QIAreach®,
QIAscreen®, QIAseq®, QIAsphere®, QIAstat-Dx®, QIAsure®, QIAsymphony®, QIAxcel®,
QIAxpert®, QIAzol®, 4NS1C®, AllPrep®, Allprotect®, AllTaq®, artus®, AmniSure®,
BioRobot®, BiOstic®, Bisulfitome®, careHPV®, Certal®, Cignal®, CLC bio®,
CleanStart®, ClearMag®, CompactPrep®, CoralLoad®, CRISPR-Q®, DiagCORE®, digene®,
DirectPrep®, DML 3000®, DNeasy®, DyeEx®, EasiCollect®, EASYartus®, Effectene®,
EndoFree®, EpiTect®, ESEQuant®, EZ1®, EZ2®, EZ1&2®, FastLane®, FastSelect®,
FlexiGene®, FlexiTube®, ForenSeq®, FTA®, FusionQuant®, GEDmatch®, GelPilot®,
GeneGlobe®, Generation®, GeneSolution®, Gentra®, HC2®, HC2 High-Risk®, HC2
High-Risk HPV DNA Test®, HiPerFect®, HiSpeed®, HotStarTaq®, Hybrid Capture®,
Ingenuity®, InhibitEX®, Inhibitor Removal Technology®, Investigator®, IPA®,
ipsogen®, LifeGuard®, LNA®, LyseBlue®, MagAttract®, Making improvements in life
possible®, MaXtract®, mericon®, MinElute®, miRCURY®, miScript®, MutaQuant®,
MutaSearch®, NeuMoDx®, Omniscript®, PartoSure®, PolyFect®, PowerBiofilm®,
PowerClean®, PowerFecal®, PowerFood®, PowerLyzer®, PowerMax®, PowerMicrobiome®,
PowerPlant®, PowerSoil®, PowerViral®, PowerWater®, Prep&Amp®, ProfileQuant®,
Puregene®, Pyro®, Pyrogram®, PyroMark®, Pyrosequencing®, Q-Bond®, Q‑Solution®,
qBiomarker®, QCI®, QFM®, QFT®, Qproteome®, QuantiFast®, QuantiFERON®,
QuantiFERON Monitor®, QuantiNova®, Quantiscript®, Quantiplex®, QuantiProbe®,
QuantiTect®, Rapid Capture®, R.E.A.L.®, REPLI-g®, RNAprotect®, RNeasy®,
Rotor-Disc®, Rotor-Gene®, Rotor-Gene AssayManager®, RT²®, RT² Profiler®,
Saltonase®, Scorpions®, ScreenClust®, ScreenGel®, Sensiscript®, SensiPhi®,
SeqTarget®, SpeedXtract®, SpinClean®, StableScript®, STM®, SuperFect®,
SwiftMag®, T-Script®, therascreen®, TissueRuptor®, TopTaq®, Transfac®,
TransMessenger®, TurboCapture®, TurboFilter®, Type-it®, UltraClean®, UltraRun®,
UltraSens®, Uni-Core®, Vapor-Lock®, VeraSeq®, Verogen®, XploreDNA®, XploreRNA®.

OTHER TRADEMARKS

2D Matrix® (Thermo Fisher Scientific or its subsidiaries); Abbott® (Abbott
Laboratories); Abbott RealTime® (Abbott Laboratories); ABgene® (Thermo Fisher
Scientific or its subsidiaries); ABI 5500 SOLiD™ (Life Technologies
Corporation); ABI PRISM® (Life Technologies Corporation); Affymetrix®
(Affymetrix, Inc.); Agilent® (Agilent Technologies, Inc.); Air-Mate™ (3M); ÄKTA®
(GE Healthcare); Alexa Fluor® (Life Technologies Corporation); Amgen® (Amgen,
Inc.); AmpFlstr® (Life Technologies Corporation); Apple® (Apple Computer, Inc.);
Applied Biosystems® (Life Technologies Corporation); APTIMA® (Gen-Probe
Incorporated); ATCC® (American Type Culture Collection); Avastin® (Genentech,
Inc.); bactotype® (Indical Bioscience GMBH); BD™ (Becton Dickinson and Company);
Benzonase® (Merck KGaA, Darmstadt, Germany); BigDye™ (Life Technologies
Corporation); BioLogic™ (Bio-Rad Laboratories, Inc.); BioMag® (Polysciences
Inc.); Bio-One® (Greiner Bio-One GmbH; Bio-Rad® (Bio-Rad Laboratories, Inc.);
Bluetooth® (Blootooth SIG, Inc.); CDP-Star® (Life Technologies Corporation);
CEQ™ (Beckman Coulter, Inc.); CLART® (Genomica S.A.U. Sociedad Anònima
Unipersonal); cobas® (Roche Diagnostics Operations, Inc.); Coomassie® (ICI
[Imperial Chemical Industries] Organics Inc.); Copan® (Copan Italia S.P.A.);
Corning® (Corning, Inc.); CryoTube® (Thermo Fisher Scientific or its
subsidiaries); Cy® (GE Healthcare); DACRON® (Invista North America S.A.R.L.
Corporation); DAPase™ (UNIZYME); DART™ (Genome Diagnostics); DeepWell™ (Thermo
Fisher Scientific or its subsidiaries); DYEnamic™ (GE Healthcare); EasyXtal®
(Molecular Dimensions, Inc.); eNAT™ (Copan Italia S.P.A.); eppendorf twin.tec®
(Eppendorf AG); Eppendorf® (Eppendorf AG); ERBITUX® (ImClone LLC., a
wholly-owned subsidiary of Eli Lilly and Company); Excel® (Microsoft
Corporation); FACS® (Becton Dickinson and Company); Falcon® (Corning, Inc.);
FAM™ (Life Technologies Corporation); FPLC® (GE Healthcare); GeneAmp® (Life
Technologies Corporation); GeneChip® (Affymetrix, Inc.); GeneMapper® (Life
Technologies Corporation); GeneReader™ (Intelligent Bio-Systems, Inc.);
GeneScan® (Life Technologies Corporation); Genotyper® (Life Technologies
Corporation); GILOTRIF® (Boehringer Ingelheim International GmbH); Hard-Shell®
(Bio-Rad Laboratories, Inc.); Helix®, Helix logo (Helix Inc.); HiSeq® (Illumina,
Inc.); Horizon™ (Horizon Discovery Limited); iCycler iQ® (Bio-Rad Laboratories,
Inc.); Identifiler® (Life Technologies Corporation); llumina® (Illumina, Inc.);
Infinium® (Illumina, Inc.); Internet Explorer® (Microsoft Corporation); Ion PGM™
(Life Technologies Corporation); Ion Torrent™ (Life Technologies Corporation);
iPad® (Apple Computer, Inc.); iPod nano® (Apple Computer, Inc.); iPod® (Apple
Computer, Inc.); IRESSA® (AstraZeneca Group); iSeq® (Illumina, Inc.); J&J®
(Johnson & Johnson); JOE™ (Life Technologies Corporation); K-Y® (Johnson &
Johnson); KAPA® (Roche Group); KAPA Biosystems® (Roche Group); LIAISON®
(DiaSorin); LightCycler® (Roche Group); Luminex® (Luminex Corporation);
LYNPARZA® (Astra Zeneca Group); LyoSphere™ (BioLyph Inc.); LyoSpheres™ (BioLyph
Inc.); March of Dimes® (March of Dimes Foundation) ; Mastercycler® (Eppendorf
AG); MegaBACE™ (GE Healthcare); Merck® (Merck Sharp & Dohme Corp.); Merz® (Merz
Pharma GmbH & Co. KGaA); MethylScreen™ (Orion Genomics, LLC); Metrogel®
(Galderma S.A.); MGB™ (Epoch Biosciences); MicroAmp® (Life Technologies
Corporation); Microgard™ (Becton Dickinson and Company); Micronic™ (Micronic
Holding B.V.); Microsoft® (Microsoft Corporation); Microtainer® (Becton
Dickinson and Company); MiniSeq® (Illumina, Inc.); MiSeq® (Illumina, Inc.);
Monistat® (Johnson & Johnson); MVS® (Artel, Inc.); Mx3005P®
(Stratagene); MyChoice® (Myriad Genetics, Inc.); MyChoice® CDx (Myriad Genetics,
Inc.); Myriad Genetics® (Myriad Genetics, Inc.); Myriad Genetics® logo (Myriad
Genetics, Inc.); Nanosep® (Pall Corporation); NASBA® (Organon Teknika); National
Comprehensive Cancer Network® (National Comprehensive Cancer Network); NCCN®
(National Comprehensive Cancer Network); NEB® (New England Biolabs, Inc.);
NEBNext® (New England Biolabs, Inc.); New England Biolabs® (New England Biolabs,
Inc.); NeXtal® (Molecular Dimensions, Inc.); NextSeq® (Illumina, Inc.);
Norforms® (C.B. Fleet Investment Corporation); NovaSeq® (Illumina, Inc.); Nunc®
(Thermo Fisher Scientific or its subsidiaries); Opera™ (Evotec Technologies);
Oragene® (DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc.);
PAXgene® (PreAnalytiX GmbH); pBluescript® (Stratagene); pGAPase™ (UNIZYME);
PIPETMAN® (Gilson Inc.); PIQRAY® (Novartis AG); PPT™ (Becton Dickinson and
Company); PrepStain® (Becton Dickinson and Company); PreservCyt® (Hologic,
Inc.); Primer Express® (Life Technologies Corporation); Puritan® (Puritan
Medical Products Company); Qcyclase™ (UNIZYME); QIAGEN GeneReader® (Intelligent
Bio-Systems, Inc.); Remp® (Remp AG); RespiFinder® (PathoFinder BV); Ribo-Zero®
(Illumina, Inc.); Roche® (Roche Group); Sarstedt® (Sarstedt AG and Co.);
SBTengine® (Genome Diagnostics); SBTexcellerator® (Genome Diagnostics);
Schering-Plough® (Merck Sharp & Dohme Corp.); Siemens® (Siemens AG); sign®
(Diatech srl); S-Monovette® (Sarstedt AG and Co.); SNaPshot™ (Life Technologies
Corporation); SSP™ (Olerup SSP AB Company, Sweden); Starlab® (Starlab Group);
SurePath® (Becton Dickinson and Company); SYBR® (Life Technologies Corporation);
TaqMan® (Roche Group); Teflon® (E. I. du Pont de Nemours and Company); Terumo®
(Terumo Europe N.V.); Thermo Scientific® (Thermo Fisher Scientific or its
subsidiaries); Thermo-Fast® (Thermo Fisher Scientific or its subsidiaries);
ThinPrep® (Hologic, Inc.); TRACKMAN® (Gilson Inc.); TraXis® (Micronic Holding
B.V.); TruSeq® (Illumina, Inc.); Tubersol® (Sanofi Pasteur Ltd.); Vacuette®
(Greiner Bio-One GmbH); Vacutainer® (Becton Dickinson and Company); Vagisan™
(Dr. August Wolff, GmbH & Co. KG Arzneimittel); Vagisil® (Combe Incorporated);
Vectibix® (Immunex Corporation); Venoject® (Terumo Europe N.V.); Venosafe®
(Terumo Europe N.V.); VEROGEN® (Verogen Inc.); Vertex® (Vertex Pharmaceuticals
Incorporated); VIC® (Life Technologies Corporation); virotype® (Indical
Bioscience GMBH); Whatman® (Whatman International Limited Corporation); Windows®
(Microsoft Corporation); Yeast Gard® (TCF National Bank). All other trademarks
are the property of their respective owners.

DISCLAIMERS

Registered names, trademarks, etc. used in the QIAGEN website, even when not
specifically marked as such, are not to be considered unprotected by law.

External links on this web site are provided only for the convenience of QIAGEN
web site visitors. QIAGEN has no interest in, responsibility for, or control
over non-QIAGEN affiliated linked sites. QIAGEN makes no promises or warranties
of any kind, express or implied, including those of merchantability and fitness
for a particular purpose, as to content of linked sites. In no event shall
QIAGEN be liable for any damages resulting from use of these links even if
QIAGEN has been informed of the possibility of such liability.

Differential display technology is covered by US patent No. 5,262,311 and other
pending patents licensed to GenHunter Corporation.

ImmunEasy technology is covered by U.S. Patents 6,194,388 and 6,207,646
exclusively licensed by Coley Pharmaceutical Group, Inc.

The SAGE process is covered by U.S. Patent 5,695,937 owned by Genzyme Molecular
Oncology.

TAGZyme technology is licensed under U.S. Patent No. 5,691,169, U.S. Patent No.
5,783, 413, and E.U. Patent No. 00759931B1.

Hoffmann-La Roche owns patents and patent applications pertaining to the
application of Ni-NTA resin (in certain countries) and to 6xHis-coding vectors
and His-labeled proteins. All purification of recombinant proteins by Ni NTA
chromatography for commercial purposes, and the commercial use of proteins so
purified, require a license from Hoffmann-La Roche in certain countries.

NOTICE TO PURCHASER: LIMITED LICENCE

'Black Hole Quencher,' 'BHQ', 'CAL Fluor', and Quasar are registered trademarks
of Biosearch Technologies, Inc.. Novato, CA. BHQ technology is the subject of US
Patent No. 7,019,129, CAL Fluor technology is the subject of US Patent No.
7,344,701, and Quasar dyes are subject to US Patent 7,705,150.

QIAGEN products incorporating the BHQ, CAL Fluor, and Quasar dyes are licensed
and sold under agreement with Biosearch Technologies, lnc.

These products are sold for use by the end-user only and may not be re-sold,
distributed or repackaged except for authorized OEM Customers.

For products comprising Scorpions Primers:
This product is sold under license from PHRI Properties.

The PAXgene Blood RNA System (cat. nos. 762105, 762115, 762331, and 762134) and
the PAXgene Blood DNA System (cat. nos. 761105, 761115, 761125, 761132, and
761133) are for research use only and not for use in diagnostic procedures.

The PAXgene Blood RNA Kit (cat. nos. 762164 and 762174) is for in vitro
diagnostic use. Not available in all countries.

The PAXgene Blood RNA MDx Kit (cat. no. 762461) is intended as a general-purpose
device for laboratory use. No claim or representation is intended for its use to
identify any specific organism or for clinical use (diagnostic, prognostic,
therapeutic, or blood banking). It is the user’s responsibility to validate the
performance of the PAXgene Blood RNA MDx Kit for any particular use, since the
performance characteristics of these kits have not been validated for any
specific organism. The performance characteristics of this product have not been
fully established.

siRNA technology is licensed to QIAGEN under European Patent 1 144 623 and
foreign equivalents from Alnylam Pharmaceuticals, Inc., Cambridge, USA and is
provided only for use in academic and commercial research (excluding the
evaluation or characterization of this product as the potential basis for a
siRNA-based drug) and not for any other commercial purposes. Information about
licenses for commercial use (including discovery and development of siRNA-based
drugs) is available from Alnylam Pharmaceuticals, Inc., 300 Third Street,
Cambridge, MA 02142, USA.

siRNA technology is licensed to QIAGEN from the Massachusetts Institute of
Technology under United States Patent Application 09/821,832 and corresponding
US and foreign patent applications. siRNA technology is licensed to QIAGEN from
the Carnegie Institute of Washington under United States Patent 6,506,559 and
corresponding US and foreign patent applications.

"RNAlater®" is a trademark of AMBION, Inc., Austin, Texas and is covered by
various U.S. and foreign patents.

RNAlater® may not be re-sold or used for commercial purposes, which both require
a specific license.

"Intelli-Plate™" is a trademark of Art Robbins Instruments, LLC.

National Comprehensive Cancer Network®, NCCN®, NCCN GUIDELINES® (National
Comprehensive Cancer Network, Inc.). NCCN GUIDELINES® referenced with permission
from The NCCN Clinical Practice Guidelines in Oncology® for Colon Cancer
V.3.2012. © National Comprehensive Cancer Network, Inc 2012. All rights
reserved. Accessed June 15, 2012. To view the most recent and complete version
of the guideline, go online to www.nccn.org.

Oregon Green and Texas Red are licensed from Molecular Probes, Inc.

Oligotex products are not available in Japan.

Strep-tag technology for protein purification and detection is covered by US
patent 5,506,121, UK patent 2272698 and French patent 93 13 066; Strep-Tactin is
covered by US patent 6,103,493.

The QIAGEN BioRobot MDx DSP workstation and QIAamp DSP kits comply with EU
Directive 98/79/EC on in vitro diagnostic medical devices. Other (non-DSP)
QIAGEN workstations and kits are intended as general-purpose devices. No claim
or representation is intended for their use to identify any specific organism or
for a specific clinical use (diagnostic, prognostic, therapeutic, or blood
banking). It is the user’s responsibility to validate the performance of QIAGEN
non-DSP workstations and kits for any particular use, since their performance
characteristics have not been validated for any specific organism. QIAGEN
non-DSP workstations and kits may be used in clinical diagnostic laboratory
systems after the laboratory has validated their complete system as required by
CLIA '88 regulations in the U.S. or equivalents in other countries.

QIAGEN REPLI-g Kits are for use only as licensed by Amersham Biosciences Corp
(part of GE Healthcare Bio-Sciences) and QIAGEN GmbH. The Phi 29 DNA polymerase
may not be re-sold or used except in conjunction with the other components of
this kit. The REPLI-g Kit is developed, designed, and sold for research purpose
only.

Benzonase® Nuclease is supplied by Merck KGaA and its Affiliates. Benzonase® is
a registered trademark of Merck KGaA, Darmstadt, Germany.

The QuantiTect Whole Transcriptome Kit is for use only as licensed by Amersham
Biosciences Corp (part of GE Healthcare Bio-Sciences) and QIAGEN GmbH. The Phi
29 DNA polymerase may not be re-sold or used except in conjunction with the
other components of this kit. The QuantiTect Whole Transcriptome Kit is
developed, designed, and sold for research purpose only.

This multiplex PCR product is licensed under US5,582,989 and corresponding
patents.

SBTexcellerator HLA Kits are licensed from Genome Diagnostics BV. QIAGEN acts as
a co-exclusive distributor of SBTengine software.

The NeuMoDx™ 96 Molecular System and the NeuMoDx™ 288 Molecular System are
covered by U.S. Patent Nos. 7,998,708; 8,323,900; 8,415,103; 8,709,787;
10,494,663; 10,364,456; 10,443,088; 10,604,788; 10,625,261; 10,625,262; and
10,632,466 owned by HandyLab, Inc. (an affiliate of Becton, Dickinson and
Company).

QUANTIFAST SYBR GREEN PCR KIT, QUANTITECT SYBR GREEN PCR KIT, QUANTIFAST SYBR
GREEN RT-PCR KIT, QUANTITECT SYBR GREEN RT-PCR KIT, FASTLANE CELL SYBR GREEN
KIT, AND MISCRIPT SYBR GREEN PCR KIT

Use of this product is covered by one or more of the following US patents and
corresponding patent claims outside the US: 5,994,056 and 6,171,785. The
purchase of this product includes a limited, nontransferable immunity from suit
under the foregoing patent claims for using only this amount of product for the
purchaser's own internal research. No right under any other patent claim and no
right to perform commercial services of any kind, including without limitation
reporting the results of purchaser's activities for a fee or other commercial
consideration, is conveyed expressly, by implication, or by estoppel. This
product is for research use only. Diagnostic uses under Roche patents require a
separate license from Roche. Further information on purchasing licenses may be
obtained by contacting the Director of Licensing, Applied Biosystems, 850
Lincoln Centre Drive, Foster City, California 94404, USA.

QUANTITECT SYBR GREEN PCR KIT, QUANTITECT SYBR GREEN RT-PCR KIT, QUANTITECT
PROBE PCR KIT, QUANTITECT PROBE RT-PCR KIT, QUANTITECT MULTIPLEX PCR KITS,
QUANTITECT MULTIPLEX RT-PCR KITS, FASTLANE CELL SYBR GREEN KIT, FASTLANE CELL
PROBE KIT, FASTLANE CELL MULTIPLEX KITS, AND MISCRIPT SYBR GREEN PCR KIT
NOTICE TO PURCHASER: LIMITED LICENSE

The use of this product is covered by at least one claim of U.S. Patent No.
7,687,247 owned by Life Technologies Corporation. The purchase of this product
conveys to the buyer the non-transferable right to use the purchased amount of
the product and components of the product in research conducted by the buyer
(whether the buyer is an academic or for-profit entity). The buyer cannot sell
or otherwise transfer (a) this product, (b) its components, or (c) materials
made by the employment of this product or its components to a third party or
otherwise use this product or its components or materials made by the employment
of this product or its components for Commercial Purposes. Commercial Purposes
means any activity for which a party receives or is due to receive consideration
and may include, but is not limited to: (1) use of the product or its components
in manufacturing; (2) use of the product or its components to provide a service,
information, or data; (3) use of the product or its components for therapeutic,
diagnostic or prophylactic purposes; or (4) resale of the product or its
components, whether or not such product or its components are resold for use in
research. The buyer cannot use this product or its components or materials made
using this product or its components for therapeutic, diagnostic or prophylactic
purposes. Further information on purchasing licenses under the above patents may
be obtained by contacting the Licensing Department, Life Technologies
Corporation, 5791 Van Allen Way, Carlsbad, CA 92008. Email:
outlicensing@lifetech.com.

QUANTITECT PRIMER ASSAYS AND MISCRIPT PRIMER ASSAYS

No license is conveyed with the purchase of this product under any ofUS Patents
Nos. 5,804,375, 5,994,056, 6,171,785, 5,538,848, 5,723,591, 5,876,930,
6,030,787, and 6,258,569, and corresponding patents ontside the United States,
or any other patents or patent applications, relating to the 5' Nuclease and
dsDNA-Binding Dye Processes. For further information contact the Director of
Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California
94404, USA.

QUANTITECT CUSTOM ASSAYS

Purchase of this product carries with it a limited, non-transferable,
non-exclusive (without the right to resell, repackage, or sublicense) license
under U.S. Patent Nos. 6,030,787; 5,723,591; and 5,876,930, and corresponding
foreign patents. No other license under these patents or any other patents is
granted expressly, impliedly, or by estoppel. No license under the PCR process
is conveyed through purchase of this product. This limited license permits the
person or legal entity to which this product has been provided to use the
product, and the data generated by use of the product, only for its internal
research purposes involving hybridization-based analysis of nucleic acids in the
ordinary course of Buyer’s normal internal research and development activities
within the life sciences field (including without limitation, drug discovery,
drug development, medical research, fermentation research and agricultural
research). The product may not be used for any other commercial, clinical,
diagnostic or any other use, including, without limitation any human or animal
diagnostic uses (including any use of the results of any testing performed with
this product in making therapeutic or treatment decisions for a patient),
industrial (including food industry) testing, forensic testing, environmental
testing (including bio-terrorism and bio-warfare), or any use of these products
to provide services of any kind. Buyer agrees and understands it is not licensed
to (a) provide commercial data or databases to or on behalf of any third party
that relate to use of the product; or (b) use the product or data there from in
a clinical diagnostic setting where data from an individual’s sample is given to
such individual or their caregiver. Neither Nanogen nor its licensors grants any
other licenses, express or implied, to permit the manufacture, use, sale, or
importation of the product, any other nucleic acids, or any data generated from
use of the product. This product or portions hereof are subject to proprietary
rights of Nanogen, Inc. and this product is made and sold under license from
Nanogen under Nanogen’s patents and patent applications and there is no implied
license for any other use with respect to this product. A license must be
obtained directly from Nanogen with respect to any other proposed use of this
product.

Powered by innovation from Nanogen
Manufactured for QIAGEN by Nanogen

FOR PRODUCTS COMPRISING ROX DYE

The purchase of this product includes a limited, non-transferable right to use
the purchased amount of the product to perform Applied Biosystems’ patented
Passive Reference Method for the purchaser’s own internal research. No right
under any other patent claim and no right to perform commercial services of any
kind, including without limitation reporting the results of purchaser's
activities for a fee or other commercial consideration, is conveyed expressly,
by implication, or by estoppel. This product is for research use only. For
information on obtaining additional rights, please contact
outlicensing@lifetech.com or Out Licensing, Life Technologies, 5791 Van Allen
Way, Carlsbad, California 92008.

ROTOR-GENE Q

For applicable countries:
The purchase of this product includes a limited, non-transferable license to one
or more of US Patents Nos 6,787,338; 7,238,321; 7,081,226; 6,174,670; 6,245,514;
6,569,627; 6,303,305; 6,503,720; 5,871,908; 6,691,041; 7,387,887; and U.S.
Patent Applications Nos. 2003-0224434 and 2006- 0019253 and all continuations
and divisionals, and corresponding claims in patents and patent applications
outside the United States, owned by the University of Utah Research Foundation,
Idaho Technology, Inc., and/or Roche Diagnostics GmbH, for internal research use
or for non-in vitro diagnostics applications. No right is conveyed, expressly,
by implication or estoppel, for any reagent or kit, or under any other patent or
patent claims owned by the University of Utah Research Foundation, Idaho
Technology, Inc., and/or Roche Diagnostics GmbH, or by any other Party. For
information on purchasing licences for in-vitro diagnostics applications or
reagents, contact Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA
94588, USA.

For applicable countries:
This real-time thermal cycler is licensed under pending U.S. Patent rights for
an apparatus or system covering automated thermal cyclers with fluorescence
detectors and seeking priority to U.S. Serial No. 07/695,201 and corresponding
claims in any foreign counterpart patent thereof owned by Applied Biosystems
LLC, in all fields, including research and development, all applied fields, and
human and animal in-vitro diagnostics. No rights are conveyed expressly, by
implication or estoppel to any patents on real-time methods, including but not
limited to 5‘ nuclease assays, or to any patent claiming a reagent or kit. For
further information on purchasing additional rights, contact the Director of
Licensing at Applied Biosystems, 850 Lincoln Centre Drive, Foster City,
California, 94404, USA.

ROTOR-GENE Q MDX

For applicable countries:
The purchase of this product includes a limited, non-transferable license to one
or more of U.S. Patent Nos. 6,787,338; 7,238,321; 7,081,226; 6,174,670;
6,245,514; 6,569,627; 6,303,305; 6,503,720; 5,871,908; 6,691,041; 7,387,887;
7,273,749; 7,160,998; U.S. Patent Application Nos. 2003-0224434 and
2006-0019253, and PCT Patent Application No. WO 2007/035806, and all
continuations and divisionals, and corresponding claims in patents and patent
applications outside the United States, owned by the University of Utah Research
Foundation, Idaho Technology, Inc., Evotec Biosystems GmbH, and/or Roche
Diagnostics GmbH for human or animal in-vitro diagnostics only. No right is
conveyed, expressly, by implication or estoppel, for any reagent or kit, or
under any other patent or patent claims owned by the University of Utah Research
Foundation, Idaho Technology, Inc., Roche Diagnostics GmbH, or by any other
Party. This product may be operated only with authorized reagents such as fully
licensed QIAGEN kits and assays. For information on purchasing licenses for
in-vitro diagnostics applications or reagents, please contact Roche Molecular
Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.

For applicable countries:
This real-time thermal cycler is licensed under pending U.S. Patent rights for
an apparatus or system covering automated thermal cyclers with fluorescence
detectors and seeking priority to U.S. Serial No. 07/695,201 and corresponding
claims in any foreign counterpart patent thereof owned by Applied Biosystems
LLC, in all fields, including research and development, all applied fields, and
human and animal in-vitro diagnostics. No rights are conveyed expressly, by
implication or estoppel to any patents on real-time methods, including but not
limited to 5‘ nuclease assays, or to any patent claiming a reagent or kit. For
further information on purchasing additional rights, contact the Director of
Licensing at Applied Biosystems, 850 Lincoln Centre Drive, Foster City,
California, 94404, USA.

EPITECT METHYL QPCR ARRAYS, EPITECT METHYL QPCR ASSAYS, AND EPITECT METHYL DNA
RESTRICTION KIT

Purchaser agrees that use of this product and data therefrom is limited solely
to the purchaser and for only the purchaser’s own internal molecular biology
research applications (“Permitted Use”), and shall not be re-sold or used for
any other purposes (all of which are expressly prohibited), including without
limitation diagnostic purposes, uses that could require regulatory approval for
diagnostics from an agency of any government or regulatory entity anywhere in
the world, diagnosis, prevention, or treatment of disease, and the right to
perform commercial services of any kind, including without limitation, reporting
the results of purchaser’s activities, including without limitation, for a fee
or other commercial consideration. Except for the Permitted Use, no rights,
titles, or interests in or to any tangible or intangible property rights are
conveyed or shall be deemed conveyed by implication, estoppel or otherwise. The
performance characteristics of the product other than for the Permitted Use are
unknown.

QIACUITY DPCR INSTRUMENTS, CONSUMABLES, AND ASSAYS

QIAcuity Digital PCR instruments are sold under license from Bio-Rad
Laboratories, Inc. and exclude rights for use with pediatric applications.

QIAcuity consumables and assays are sold under license from Bio-Rad
Laboratories, Inc. for use on QIAcuity Digital PCR instruments and exclude
rights for use with pediatric applications.

QUANTIFERON-TB GOLD PLUS

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection
of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M.
tuberculosis infection (including disease) and is intended for use in
conjunction with risk assessment, radiography, and other medical and diagnostic
evaluations. QFT-Plus package inserts, up-to-date licensing information and
product-specific disclaimers can be found at www.QuantiFERON.com.

Country and Language
Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica
Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas
Bahrain Bangladesh Barbados Belgium Belize Benin Bermuda Bhutan Bolivia
(Plurinational State of) Bosnia and Herzegovina Botswana Bouvet Island Brazil
British Indian Ocean Territory British Virgin Islands Brunei Darussalam (Brunei)
Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands
Central African Republic Chad Chile China Christmas Island Cocos (Keeling)
Islands Colombia Comoros Congo Cook Islands Costa Rica Croatia Cyprus Czech
Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican
Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia
Falkland Islands (Malvinas) Faroe Islands Federated States of Micronesia Fiji
Finland France French Guiana French Polynesia French Southern Territories Gabon
Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam
Guatemala Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands
Honduras Hong Kong Hungary Iceland India Indonesia Iraq Ireland Israel Italy
Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao
People's Democratic Republic Latvia Lebanon Lesotho Liberia Libia Liechtenstein
Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta
Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Moldova Monaco
Mongolia Montserrat Morocco Mozambique Myanmar (Burma) Namibia Nauru Nepal
Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger
Nigeria Niue North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau
Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland
Portugal Puerto Rico Qatar Reunion Romania Rwanda Saint Helena, Ascension and
Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon
Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi
Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia
Solomon Islands Somalia South Africa South Georgia and the South Sandwich
Islands South Korea Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen
Swaziland Sweden Switzerland Taiwan Tajikistan Tanzania Thailand Togo Tokelau
Timor-Leste Tonga Trinidad and Tobago Tunisia Türkiye Turkmenistan Turks and
Caicos Islands Tuvalu U.S. Virgin Islands Uganda Ukraine United Arab Emirates
United Kingdom United States Minor Outlying Islands United States of America
Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wallis and Futuna
Western Sahara Yemen Zambia Zimbabwe
Select Language English Chinese (Simplified, PRC) French German Japanese (Japan)
Korean (Korea) Spanish
Follow Us
 * icon_0065_instagram-s
 * icon_0064_facebook-s
 * icon_0340_cc_gen_x-s
 * icon_0077_youtube-s
 * icon_0066_linkedin-s
   

Contact Us
 * icon_0072_phone-s
 * icon_0063_envelope-s
   

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of
Service apply.

Sample to Insight
© QIAGEN 2013–24. All rights reserved
Trademarks & DisclaimersTerms & ConditionsPrivacyConsent
ManagerAccessibilityCancellation and ReturnsImpressum